These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2372904)

  • 1. Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis.
    Gruber A; Hanson SR; Kelly AB; Yan BS; Bang N; Griffin JH; Harker LA
    Circulation; 1990 Aug; 82(2):578-85. PubMed ID: 2372904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic effects of combining activated protein C and urokinase in nonhuman primates.
    Gruber A; Harker LA; Hanson SR; Kelly AB; Griffin JH
    Circulation; 1991 Dec; 84(6):2454-62. PubMed ID: 1835678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model.
    Gruber A; Griffin JH; Harker LA; Hanson SR
    Blood; 1989 Feb; 73(3):639-42. PubMed ID: 2917194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic effects of orally active synthetic antagonist of activated factor X in nonhuman primates.
    Yokoyama T; Kelly AB; Marzec UM; Hanson SR; Kunitada S; Harker LA
    Circulation; 1995 Aug; 92(3):485-91. PubMed ID: 7634464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble thrombomodulin is antithrombotic in the presence of neutralising antibodies to protein C and reduces circulating activated protein C levels in primates.
    Tanaka KA; Fernández JA; Marzec UM; Kelly AB; Mohri M; Griffin JH; Hanson SR; Gruber A
    Br J Haematol; 2006 Jan; 132(2):197-203. PubMed ID: 16398653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.
    Hanson SR; Griffin JH; Harker LA; Kelly AB; Esmon CT; Gruber A
    J Clin Invest; 1993 Oct; 92(4):2003-12. PubMed ID: 8408654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihemostatic and antithrombotic effects of monoclonal antibodies against von Willebrand factor in nonhuman primates.
    Krupski WC; Bass A; Cadroy Y; Kelly AB; Harker LA; Hanson SR
    Surgery; 1992 Aug; 112(2):433-9; discussion 439-40. PubMed ID: 1641780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective factor Xa inhibition by recombinant antistasin prevents vascular graft thrombosis in baboons.
    Schaffer LW; Davidson JT; Vlasuk GP; Dunwiddie CT; Siegl PK
    Arterioscler Thromb; 1992 Aug; 12(8):879-85. PubMed ID: 1637785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative antithrombotic and antihemostatic effects of protein C activator versus low-molecular-weight heparin in primates.
    Gruber A; Marzec UM; Bush L; Di Cera E; Fernández JA; Berny MA; Tucker EI; McCarty OJ; Griffin JH; Hanson SR
    Blood; 2007 May; 109(9):3733-40. PubMed ID: 17227834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lasting safe interruption of endarterectomy thrombosis by transiently infused antithrombin peptide D-Phe-Pro-ArgCH2Cl in baboons.
    Lumsden AB; Kelly AB; Schneider PA; Krupski WC; Dodson T; Hanson SR; Harker LA
    Blood; 1993 Apr; 81(7):1762-70. PubMed ID: 8461462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hirudin interruption of heparin-resistant arterial thrombus formation in baboons.
    Kelly AB; Marzec UM; Krupski W; Bass A; Cadroy Y; Hanson SR; Harker LA
    Blood; 1991 Mar; 77(5):1006-12. PubMed ID: 1995089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interruption of vascular thrombus formation and vascular lesion formation by dietary n-3 fatty acids in fish oil in nonhuman primates.
    Harker LA; Kelly AB; Hanson SR; Krupski W; Bass A; Osterud B; FitzGerald GA; Goodnight SH; Connor WE
    Circulation; 1993 Mar; 87(3):1017-29. PubMed ID: 8443878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic activity of protein S infused without activated protein C in a baboon thrombosis model.
    Heeb MJ; Marzec U; Gruber A; Hanson SR
    Thromb Haemost; 2012 Apr; 107(4):690-8. PubMed ID: 22370911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model.
    Cadroy Y; Houghten RA; Hanson SR
    J Clin Invest; 1989 Sep; 84(3):939-44. PubMed ID: 2760221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition by a synthetic hirudin peptide of fibrin-dependent thrombosis in baboons.
    Cadroy Y; Maraganore JM; Hanson SR; Harker LA
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1177-81. PubMed ID: 1996320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of platelet-dependent thrombosis by low molecular weight heparin (CY222): comparison with standard heparin.
    Cadroy Y; Harker LA; Hanson SR
    J Lab Clin Med; 1989 Oct; 114(4):349-57. PubMed ID: 2551985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone.
    Hanson SR; Harker LA
    Proc Natl Acad Sci U S A; 1988 May; 85(9):3184-8. PubMed ID: 3362867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A four-hour infusion of recombinant hirudin results in long-term inhibition of arterial-type thrombosis in baboons.
    Kotzé HF; Lamprecht S; Badenhorst PN
    Blood; 1995 Jun; 85(11):3158-63. PubMed ID: 7756648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local delivery of an antithrombin inhibits platelet-dependent thrombosis.
    Scott NA; Nunes GL; King SB; Harker LA; Hanson SR
    Circulation; 1994 Oct; 90(4):1951-5. PubMed ID: 7923684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatan sulfate inhibition of fibrin-rich thrombus formation in nonhuman primates.
    Cadroy Y; Hanson SR; Harker LA
    Arterioscler Thromb; 1993 Aug; 13(8):1213-7. PubMed ID: 8343496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.